90 related articles for article (PubMed ID: 3547357)
1. [Clinical evaluation of ceftazidime and the combined administration of cefotaxime and tobramycin in the treatment of urinary tract infections. Prospective and randomized studies].
Wiecek A; Kokot F; Andrzejowska H; Grzeszczak W
Pol Tyg Lek; 1986 Sep; 41(39):1242-6. PubMed ID: 3547357
[No Abstract] [Full Text] [Related]
2. [Randomized prospective study of ceftazidime versus a cefotaxime-tobramycin combination in acute leukemia in therapeutic aplasia].
Pellegrin JL; Marit G; Fourche J; Broustet A; Texier-Maugein J; Leng B; Reiffers J
Presse Med; 1988 Oct; 17(37):1960-3. PubMed ID: 2973596
[TBL] [Abstract][Full Text] [Related]
3. Tobramycin once-a-day vs cefoperazone twice-a-day in the therapy of urinary tract infections.
Bonadio M; Maccanti O; Cosci S; Benvenuti S
J Chemother; 1989 Jul; 1(4 Suppl):860-1. PubMed ID: 16312673
[No Abstract] [Full Text] [Related]
4. [Clinical efficacy and safety of the cefamandole-tobramycin combination in the prevention and treatment of surgical infections in high-risk patients].
Ricci L; Rosati F; Belbusti F
Chir Patol Sper; 1983 Dec; 31(6):231-40. PubMed ID: 6400083
[No Abstract] [Full Text] [Related]
5. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
Rothwell DL; Bremner DA; Taylor KM
N Z Med J; 1983 May; 96(732):392-4. PubMed ID: 6302612
[TBL] [Abstract][Full Text] [Related]
6. Cefotaxime in a single daily dose in lower urinary tract infections.
Peralta S; Affronti M; Malta R; Delle Vedove G; Pirrotta P; Rotondo G; Paternostro D; Rini GB; Di Rosa S
J Chemother; 1989 Jul; 1(4 Suppl):847-8. PubMed ID: 16312666
[No Abstract] [Full Text] [Related]
7. [Current role of aminoglycosides in the treatment of acute pyelonephritis].
Caron F
Prog Urol; 1998 Dec; 8(6):1077-9. PubMed ID: 9894273
[TBL] [Abstract][Full Text] [Related]
8. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
Smith CR; Ambinder R; Lipsky JJ; Petty BG; Israel E; Levitt R; Mellits ED; Rocco L; Longstreth J; Lietman PS
Ann Intern Med; 1984 Oct; 101(4):469-77. PubMed ID: 6089633
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
[TBL] [Abstract][Full Text] [Related]
10. Complicated urinary tract infections treated with ceftazidime and tobramycin: a comparative study.
Madsen PO; Frimodt-Møller PC
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():77-9. PubMed ID: 6352658
[TBL] [Abstract][Full Text] [Related]
11. Single-dose ceftriaxone versus multi-dose cefotaxime as short-term antimicrobial prophylaxis in urologic surgery. Preliminary results of a multicenter prospective randomized study.
Periti P; Mazzei T; Lamanna S; Mini E
Chemioterapia; 1984 Oct; 3(5):295-8. PubMed ID: 6099756
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
Arich C; Gouby A; Bengler C; Ardilouze JL; Dubois A; Joubert P; Hansel S; Janbon C; Fabre S
Pathol Biol (Paris); 1987 May; 35(5):613-5. PubMed ID: 3302868
[TBL] [Abstract][Full Text] [Related]
13. A multiple-center comparative study of the kidney tolerance of ceftazidime versus cefotaxime and tobramycin.
Mondorf A; Mondorf W; Banzer S
Chemioterapia; 1987 Jun; 6(2 Suppl):331-2. PubMed ID: 2908241
[No Abstract] [Full Text] [Related]
14. [Clinical results and safety of ceftazidime, a new injectable cephalosporin, in long-term administration of the treatment of infections in urology].
Suzuki K; Tamai H; Naide Y; Fujita T; Ogawa T; Yanaoka M; Nagakubo I; Moriguchi R; Okishio N; Ishiguro K
Hinyokika Kiyo; 1984 Nov; 30(11):1711-35. PubMed ID: 6397060
[TBL] [Abstract][Full Text] [Related]
15. Short-term antibiotherapy for peritonitis: prospective, randomized trial comparing cefotaxime-metronidazole and clindamycin-tobramycin.
Biron S; Brochu G; Béland L; Bourque RA; Marceau P; Piché P; Potvin M
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():213-6. PubMed ID: 6094442
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the effectiveness and renal tolerance of aztreonam (1 daily dosage) and gentamycin (2 daily doses) in the therapy of renal and urinary infections].
Bonadio M; Maccanti O; Pulitanò L; Galigani P; Palla R
G Ital Chemioter; 1985; 32(2):459-63. PubMed ID: 3914435
[No Abstract] [Full Text] [Related]
17. [The therapeutic effect of a single administration of 1g of cefotaxime in urinary tract infections].
Prát V; Horcicková M; Milotová Z; Matousovic K; Hatala M
Cas Lek Cesk; 1986 Aug; 125(35):1097-9. PubMed ID: 3757001
[No Abstract] [Full Text] [Related]
18. [The Nebicin-Keflin combination in complicated urological infections].
Marascia G; Magnocavallo N; Gaspari G; Berardi D; Petrone U
Minerva Urol; 1982; 34(1):59-62. PubMed ID: 7087944
[No Abstract] [Full Text] [Related]
19. A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
Cox CE
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():47-52. PubMed ID: 6352654
[TBL] [Abstract][Full Text] [Related]
20. Ceftazidime, a new cephalosporin in the treatment of complicated urinary tract infections: a comparative study with tobramycin.
Frimodt-Møller PC; Madsen PO
J Urol; 1983 Oct; 130(4):796-7. PubMed ID: 6350625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
